An intensified manufacturing process developed to support a trial of an Ebola vaccine in Uganda could help accelerate the production of other jabs in future health emergencies, according to ...

The entire process of manufacturing a flu shot — from fertilized egg to a syringe at a doctor’s office — takes about six months, according to the CDC. Influenza virus is injected into ...

Groundbreaking results achieved by Irish biotech Ovagen Group could "transform the economics of global vaccine manufacturing", the company said on Wednesday. The company carried out its breakthrough ...

ICMR invites EoI for commercializing malaria vaccine technology, offering technical support and collaboration opportunities ...

Messenger RNA-based vaccine production has become a major industry focus, thanks to the success of jabs developed during the pandemic. However, under normal circumstances, DNA-based manufacturing ...

Flu Crisis Sparks Fresh Look at Vaccine Production. November 26, 2004. By Michael S. Rosenwald.

[3] Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production. Applied Microbiology and ...

Merck opened a 225,000-square-foot facility dedicated solely to expanding vaccine manufacturing. The Rahway-based research-intensive biopharmaceutical announced the launch of the $1 billion ...

The October 5 announcement by the Chiron Corporation that it could not ship nearly half the US supply of influenza vaccine has trained a spotlight on the vaccine production process. The ensuing public ...

This key milestone, achieved on schedule, will allow Naobios to scale up the production of Sumagen’s HIV-1 vaccine followed by cGMP production to launch phase I/II clinical trials by the end of ...